Yttrium-90 Ibritumomab Tiuxetan-Induced Complete Remission in a Patient with Classical Lymphocyte-Rich Hodgkin’s Lymphoma

Publisher： Karger

E-ISSN： 2296-5262|31|1-2|49-51

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.1-2, 2008-01, pp. : 49-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Yttrium-90 Ibritumomab Tiuxetan Followed by Rituximab Maintenance as Treatment for Patients with Diffuse Large B-Cell Lymphoma Are Not Candidates for Autologous Stem Cell Transplant

By  

Acta Haematologica, Vol. 133, Iss. 4, 2015-02 ,pp. : 347-353

Karger

Access to resources Recommend Favorite

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2122-2129

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case Report of Hodgkin’s Lymphoma in a Patient with Carcinosarcoma of the Bladder

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-12 ,pp. : 592-596

Karger

Access to resources Recommend Favorite

Failure of 18Fluorodeoxyglucose Positron Emission Tomography to Detect the High-Grade Transformation of Nodular Lymphocyte Predominant Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 129, Iss. 4, 2013-01 ,pp. : 229-231

Karger

Access to resources Recommend Favorite